Clincosm LogoSign in Get a demo

pulmonary vascular disease

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Vascular Disease, Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

Active, not recruiting
  • Pulmonary Vascular Disease
  • +2 more
  • Relocation from HA to LA
  • Zurich, Switzerland
    Respiratory Clinic, University Hospital of Zurich
Oct 17, 2023

Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

Active, not recruiting
  • Pulmonary Vascular Disease
  • +2 more
  • Assessment without intervention at High altitude
  • Relocation to sea level for 2 days
  • Zurich, Switzerland
    University Hospital Zurich
Oct 2, 2023

Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zürich

Recruiting
  • Pulmonary Vascular Disease
  • +2 more
  • 6-minute walk distance (6MWD) test
  • 6-minute walk distance (6MWD) test with supplemental oxygen (3 l/min, nasal)
  • Zürich, Switzerland
    University Hospital Zürich
Aug 18, 2023

Pulmonary Vascular Disease, Pulmonary Artery Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Zurich

Recruiting
  • Pulmonary Vascular Disease
  • +2 more
  • Relocation to sea level
  • Zurich, Switzerland
    University Hospital Zurich
Aug 9, 2023

Pulmonary Hypertension in Left Heart Disease

Not yet recruiting
  • Pulmonary Hypertension
  • +2 more
  • Transthoracic Echocardiography (TTE)
  • Lung ultrasound
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jun 29, 2023

Pulmonary Vascular Disease Trial in Durham (Hyperpolarized 129Xenon gas)

Recruiting
  • Pulmonary Vascular Disease
  • Hyperpolarized 129Xenon gas
  • Durham, North Carolina
    Duke University Medical Center
Oct 3, 2022

Pulmonary Vascular Disease, Pulmonary Arterial Hypertension Trial in Canada, United States

Recruiting
  • Pulmonary Vascular Disease
  • Pulmonary Arterial Hypertension
    • Palo Alto, California
    • +7 more
    Aug 10, 2022

    Pulmonary Vascular Disease Trial in Durham (GE-141, Hyperpolarized 129Xenon gas, MRI)

    Completed
    Has Results
    • Pulmonary Vascular Disease
    • GE-141, Hyperpolarized 129Xenon gas
    • MRI
    • Durham, North Carolina
      Duke University Medical Center
    Jan 28, 2022

    Pulmonary Vascular Disease Trial in Leuven (The intervention is performing an exercise test)

    Completed
    • Pulmonary Vascular Disease
    • The intervention is performing an exercise test
    • Leuven, Belgium
      University Hospitals Leuven
    May 2, 2017

    Chronic Obstructive Pulmonary, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis Trial in Worldwide (Placebo, EZ-2053, EZ-2053

    Completed
    Has Results
    • Chronic Obstructive Pulmonary
    • +4 more
    • Placebo
    • +2 more
    • Los Angeles, California
    • +18 more
    Jun 7, 2012